# Pharmacokinetic Pilot Study on Budesonide/Formoterol

> **NCT01457716** · NA · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Formoterol
- **DEVICE:** Easyhaler
- **DEVICE:** Turbohaler Forte

## Key facts

- **NCT ID:** NCT01457716
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01457716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01457716, "Pharmacokinetic Pilot Study on Budesonide/Formoterol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01457716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
